These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 321133)

  • 1. Specific elimination of cytotoxic cells. II. Reduction of cytotoxic activity by adsorption on monolayers results from removal of cytotoxic cells and not from inhibition of their activity.
    Neefe JR; Sachs DH
    Cell Immunol; 1977 Mar; 29(1):129-36. PubMed ID: 321133
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific elimination of cytotoxic effector cells. I. Adsorptive behavior of effectors and their precursors and spleen cell monolayers.
    Neefe JR; Sachs DH
    J Exp Med; 1976 Oct; 144(4):996-1008. PubMed ID: 789811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific adsorption of cytotoxic thymus-processed lymphocytes (T cells) on glutaraldehyde-fixed fibroblast monolayers.
    Golstein P; Svedmyr EA; Blomgren H
    Eur J Immunol; 1972 Aug; 2(4):380-3. PubMed ID: 4628413
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific separation of cytotoxic T lymphocytes on immunoadsorptive films.
    Bröcker EB; Sorg C
    J Immunol Methods; 1977; 14(3-4):333-42. PubMed ID: 320271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cells that suppress the cytotoxic activity of T lymphocytes. II. Physical properties, specificity, and developmental kinetics of the inhibitory splenic non-T cell population.
    Clark DA; Phillips RA; Miller RG
    Cell Immunol; 1977 Nov; 34(1):25-37. PubMed ID: 71952
    [No Abstract]   [Full Text] [Related]  

  • 7. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption on B cell hybridomas removes suppressor cells from spleen cells of neonatally tolerized mice.
    Stockinger B; Darjes H; Krammer PH
    Eur J Immunol; 1986 Mar; 16(3):301-5. PubMed ID: 2937642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes.
    Golstein P; Erik MD; Svedmyr AJ; Wigzell H
    J Exp Med; 1971 Dec; 134(6):1385-402. PubMed ID: 5001703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.
    Shearer GM
    Eur J Immunol; 1974 Aug; 4(8):527-33. PubMed ID: 4547153
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for non T-cells in the generation of cytotoxic T lymphocytes (CTL) in vitro. II. Characterization of the active cells in the spleen of nude mice.
    Miller RG; Shcilling RM; Phillips RA
    J Immunol; 1977 Jan; 118(1):166-74. PubMed ID: 299753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of F1 hybrid antiparent cytotoxic effector cells: an in vitro model for hemopoietic histoincompatibility.
    Shearer GM; Cudkowicz G
    Science; 1975 Nov; 190(4217):890-3. PubMed ID: 1188368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inactivation of cytotoxic lymphocytes after adsorption on 51Cr-labeled fibroblast monolayers.
    Ritter J; Lohmann-Matthes ML; Fischer H
    Transplantation; 1973 Dec; 16(6):579-82. PubMed ID: 4148250
    [No Abstract]   [Full Text] [Related]  

  • 17. The separation of sub-populations of T and B lymphocytes.
    Shortman K; Cerottini JC; Brunner KT
    Eur J Immunol; 1972 Aug; 2(4):313-9. PubMed ID: 4563345
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase in the concentration of effector T-lymphocytes specific for H-2 antigens. II. Removal of B-lymphocytes from an eluted population of cytotoxic T-cells].
    Brondz BD; Egorova SG; Kotomina IF
    Tsitologiia; 1976 Dec; 18(12):1484-9. PubMed ID: 799855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.